Open access
2026
Dihydroquercetin alleviates mitochondrial dysfunction and inhibits NLRP3-mediated pyroptosis in primary hepatocytes from chronic liver failure patients.
DHQ exerts multidimensional protective effects on hepatocytes, providing a novel strategy and clinical evidence for mitochondria-targeted CLF therapy.
Ao Shen, Peng-Xiang Wang, Bing Wu et al.
· American journal of translat... · 0 citations